Cost, Lack of Expertise Major Barriers to Precision Medicine Programs

Cost, Lack of Expertise Major Barriers to Precision Medicine Programs

Precision medicine and genomics hold the promise of more personalized care delivery and improved patient outcomes. However, there are still significant challenges to implementing precision medicine initiatives, hindering organizations’ ability to provide better care. Organizations have shown limited establishment of precision medicine programs in the past year, with cost and a lack of expertise as the most commonly cited barriers to these programs, according to a recent survey from Definitive Healthcare. The organization surveyed healthcare leaders at acute care organizations from September to October 2019 to uncover strategic approaches to care, greatest challenges for existing precision medicine programs, and barriers for entry into the space. The survey showed a limited establishment of precision medicine programs in 2019, at just 20.5 percent, and minimal growth over the next few years, at just 13.4 percent. However, the results also showed that the number of disease focus areas have already increased in just a few years’ time.

Medigy Insights

Precision medicine and genomics hold promise for personalized care and improved patient outcomes. However, significant challenges hinder the implementation of these initiatives, limiting organizations' ability to provide better care. According to a survey by Definitive Healthcare, cost and lack of expertise are major barriers to precision medicine programs. The survey, conducted among healthcare leaders in 2019, revealed that only 20.5% of organizations had established precision medicine programs, with minimal growth projected at 13.4%. Nevertheless, the study also observed an increase in the number of disease focus areas over a few years. These findings highlight the need to address barriers and foster wider adoption of precision medicine for enhanced patient care.



Next Article

  • Cost, Lack of Expertise Major Barriers to Precision Medicine Programs

    Pharma Can’t Let Big Tech Win the Race for Medical AI

    The shift to prescription digital therapeutics requires players who put evidence first, who have strong commercial and regulatory arms, and who have deep expertise in shifting the standard of care to …

    Posted Jul 5, 2023

Did you find this useful?

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.


© 2024 Netspective Foundation, Inc. All Rights Reserved.

Built on Nov 1, 2024 at 1:10pm